Alex Rodrigues Sep 25 Source: Medium | Today, Embark is proud to announce our $70 million Series C financing. The round was led by Tiger Global, with participation from Sequoia, DCVC, YCombinator, SV Angel, Maven Ventures, OMERS Ventures, and…
WI Harper Group 1 week ago EdiGene Inc., a genetic editing biotechnology company backed by WI Harper Group, announced the successful completion of the Pre-B2 round of financing of RMB 81.5 million. This round of investment was jointly invested by IDG Capital…
From: Silicon Valley Innovation & Entrepreneurship Forum SVIEF Sept 11, 2019 From September 7 to 8, 2019, the 9th Silicon Valley High-Tech Innovation and Entrepreneurship Summit (Silicon Valley High-Creation Conference) was successfully held at the Santa Clara Convention and Exhibition…
Three of WI Harper’s portfolio companies have made the 2019Venture50 preliminary evaluation list: EdiGene, Histo Pathology, CreditX Source: WI Harper Group The 2019Venture50 preliminary evaluation list was just released. Since its launch earlier this April, Venture50 has attracted 7000+ projects…
Posted by ViSenze 04-September-2019 High return rates have long been one of the core problems of online fashion sellers, with preference-based reasons like fit, size, and style driving around 72 percent of returns. One way of solving this problem is by providing customers…
WI Harper-backed Neuracle Technology Co., Ltd. has officially announced the completion of a RMB 60 million financing round. To date, Neuracle has completed three rounds of financing, with a total financing scale exceeding Rmb 100million. This round of investment was…
50 California Street Suite #2580 San Francisco, CA 94111 United States of America Tel: (415) 397-6200 Fax: (415) 397-6280
806 Tower A Pacific Century Place Beijing 100027 People’s Republic of China Tel: (86-10) 6539-1366 Fax: (86-10) 6539-1367
10F-2 Ruentex Banking Tower 76 Tun Hua South Road Sec.2 Taipei Taiwan Tel: (886-2) 2755-6033 Fax: (886-2) 2709-2127
Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.
